Micro Cap Growth Fund
Daily price w/o sales charge as of 07/08/2020
$15.34
$0.31
YTD Returns w/o sales charge as of 07/08/2020
15.69%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of micro and small-sized U.S. companies.
Fund Basicsas of 05/29/2020
- Total Net Assets
- $135.90 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Expense Ratio
- 1.31%
- Number of Holdings
- 86
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
1.31%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 11.76% | 14.09% | 21.98% | 12.83% | 18.28% | 10.18% |
| Lipper Category Avg. Small-Cap Growth Funds | 1.19% | 5.49% | 11.00% | 8.64% | 13.15% | - |
| Russell Microcap® Growth Index | 1.92% | 7.89% | 5.20% | 3.10% | 11.12% | - |
| w/ sales charge | 5.33% | 7.51% | 19.60% | 11.50% | 17.58% | 9.86% |
Fund Expense Ratio :
1.31%
Fund Expense Ratio :
1.31%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 11.76% | 14.09% | 21.98% | 12.83% | 18.28% | 10.18% |
| Lipper Category Avg. Small-Cap Growth Funds | 1.19% | 5.49% | 11.00% | 8.64% | 13.15% | - |
| Russell Microcap® Growth Index | 1.92% | 7.89% | 5.20% | 3.10% | 11.12% | - |
| w/ sales charge | 5.33% | 7.51% | 19.60% | 11.50% | 17.58% | 9.86% |
Fund Expense Ratio :
1.31%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 05/29/2020View Portfolio
| Holding | Assets |
|---|---|
| Fiverr International Ltd | 3.0% |
| Redfin Corp | 2.7% |
| EverQuote Inc | 2.4% |
| Cerence Inc | 2.3% |
| Calix Networks, Inc. | 2.2% |
| Endava PLC | 2.0% |
| ChemoCentryx Inc | 2.0% |
| TG Therapeutics, Inc. | 2.0% |
| SVMK Inc | 1.8% |
| iRhythm Technologies, Inc. | 1.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 05/29/2020View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
1.31%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 11.76% | 14.09% | 21.98% | 12.83% | 18.28% | 10.18% |
| Lipper Category Avg. Small-Cap Growth Funds | 1.19% | 5.49% | 11.00% | 8.64% | 13.15% | - |
| Russell Microcap® Growth Index | 1.92% | 7.89% | 5.20% | 3.10% | 11.12% | - |
| w/ sales charge | 5.33% | 7.51% | 19.60% | 11.50% | 17.58% | 9.86% |
Fund Expense Ratio :
1.31%
Fund Expense Ratio :
1.31%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 11.76% | 14.09% | 21.98% | 12.83% | 18.28% | 10.18% |
| Lipper Category Avg. Small-Cap Growth Funds | 1.19% | 5.49% | 11.00% | 8.64% | 13.15% | - |
| Russell Microcap® Growth Index | 1.92% | 7.89% | 5.20% | 3.10% | 11.12% | - |
| w/ sales charge | 5.33% | 7.51% | 19.60% | 11.50% | 17.58% | 9.86% |
Fund Expense Ratio :
1.31%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2019 | 34.57% | 23.33% |
| 2018 | 2.74% | -14.18% |
| 2017 | 38.43% | 16.65% |
| 2016 | 2.07% | 6.86% |
| 2015 | -6.38% | -3.85% |
| 2014 | 10.83% | 4.30% |
| 2013 | 78.53% | 52.84% |
| 2012 | 2.35% | 15.17% |
| 2011 | -5.87% | -8.42% |
| 2010 | 33.77% | 29.48% |
| 2009 | 52.61% | - |
| 2008 | -46.45% | - |
| 2007 | 22.76% | - |
| 2006 | 25.37% | - |
| 2005 | 2.55% | - |
| 2004 | 25.89% | - |
| 2003 | 49.34% | - |
| 2002 | -30.97% | - |
| 2001 | 16.96% | - |
| 2000 | -30.76% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2020 | -24.28% | 47.61% | - | - | 15.69% |
| 2019 | 22.67% | 7.47% | -13.91% | 18.57% | 34.57% |
| 2018 | 5.24% | 15.77% | 10.08% | -23.39% | 2.74% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% | 38.43% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% | 2.07% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% | -6.38% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% | 10.83% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% | 78.53% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% | 2.35% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% | -5.87% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% | 33.77% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% | 52.61% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% | -46.45% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% | 22.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% | 25.37% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% | 2.55% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% | 25.89% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% | 49.34% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% | -30.97% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% | 16.96% |
| 2000 | - | - | -4.83% | -19.30% | -30.76% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 06/30/2020
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Fiverr International Ltd | Consumer Discretionary | 3.0% |
| Redfin Corp | Real Estate | 2.7% |
| EverQuote Inc | Communication Services | 2.4% |
| Cerence Inc | Information Technology | 2.3% |
| Calix Networks, Inc. | Information Technology | 2.2% |
| Endava PLC | Information Technology | 2.0% |
| ChemoCentryx Inc | Health Care | 2.0% |
| TG Therapeutics, Inc. | Health Care | 2.0% |
| SVMK Inc | Information Technology | 1.8% |
| iRhythm Technologies, Inc. | Health Care | 1.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Fiverr International Ltd | Consumer Discretionary | 3.0% |
| Redfin Corp | Real Estate | 2.7% |
| EverQuote Inc | Communication Services | 2.4% |
| Cerence Inc | Information Technology | 2.3% |
| Calix Networks, Inc. | Information Technology | 2.2% |
| Endava PLC | Information Technology | 2.0% |
| ChemoCentryx Inc | Health Care | 2.0% |
| TG Therapeutics, Inc. | Health Care | 2.0% |
| SVMK Inc | Information Technology | 1.8% |
| iRhythm Technologies, Inc. | Health Care | 1.8% |
| Axonics Modulation Technologies Inc | Health Care | 1.7% |
| Inspire Medical Systems Inc | Health Care | 1.7% |
| Stamps.com, Inc. | Consumer Discretionary | 1.7% |
| OrthoPediatrics Corp | Health Care | 1.7% |
| Limelight Networks, Inc. | Information Technology | 1.7% |
| Sprout Social Inc | Information Technology | 1.7% |
| Papa John's International, Inc. | Consumer Discretionary | 1.6% |
| Turning Point Therapeutics Inc | Health Care | 1.5% |
| Twist Bioscience Corp | Health Care | 1.5% |
| LGI Homes, Inc. | Consumer Discretionary | 1.5% |
| Evoqua Water Technologies Corp | Industrials | 1.4% |
| Federal Signal Corp. | Industrials | 1.4% |
| SPX Corp. | Industrials | 1.4% |
| CEVA, Inc. | Information Technology | 1.3% |
| Malibu Boats, Inc. | Consumer Discretionary | 1.3% |
| Assetmark Financial Holdings Inc | Financials | 1.3% |
| Silk Road Medical Inc | Health Care | 1.3% |
| Eidos Therapeutics Inc | Health Care | 1.3% |
| Krystal Biotech Inc | Health Care | 1.3% |
| Restoration Hardware Holdings, Inc. | Consumer Discretionary | 1.2% |
| Appian Corp | Information Technology | 1.2% |
| Karuna Therapeutics Inc | Health Care | 1.2% |
| Rambus, Inc. | Information Technology | 1.2% |
| YETI Holdings Inc | Consumer Discretionary | 1.2% |
| Upland Software Inc | Information Technology | 1.2% |
| Myovant Sciences Ltd | Health Care | 1.2% |
| NanoString Technologies, Inc. | Health Care | 1.2% |
| Deciphera Pharmaceuticals Inc | Health Care | 1.2% |
| Goosehead Insurance Inc | Financials | 1.1% |
| Rocket Pharmaceuticals Inc | Health Care | 1.1% |
| Shockwave Medical Inc | Health Care | 1.1% |
| Fox Factory Holding Corp. | Consumer Discretionary | 1.1% |
| Clean Harbors, Inc. | Industrials | 1.1% |
| Arena Pharmaceuticals, Inc. | Health Care | 1.0% |
| Aerovironment, Inc. | Industrials | 1.0% |
| Schrodinger Inc/United States | Health Care | 1.0% |
| Freshpet, Inc. | Consumer Staples | 1.0% |
| Sonos Inc | Consumer Discretionary | 1.0% |
| RealReal Inc/The | Consumer Discretionary | 1.0% |
| Alector Inc | Health Care | 1.0% |
| Nevro Corp. | Health Care | 1.0% |
| elf Beauty, Inc. | Consumer Staples | 1.0% |
| Wingstop, Inc. | Consumer Discretionary | 1.0% |
| Insmed, Inc. | Health Care | 0.9% |
| Ichor Holdings Ltd | Information Technology | 0.9% |
| Cardlytics Inc | Information Technology | 0.9% |
| Trupanion Inc | Financials | 0.9% |
| Agilysys Inc | Information Technology | 0.8% |
| 8x8, Inc. | Information Technology | 0.8% |
| Chart Industries, Inc. | Industrials | 0.8% |
| Denali Therapeutics Inc | Health Care | 0.8% |
| National Vision Holdings Inc | Consumer Discretionary | 0.7% |
| Health Catalyst Inc | Health Care | 0.7% |
| Veracyte Inc | Health Care | 0.7% |
| Diodes, Inc. | Information Technology | 0.7% |
| Aurinia Pharmaceuticals Inc | Health Care | 0.6% |
| Rapid7, Inc. | Information Technology | 0.6% |
| NextCure Inc | Health Care | 0.6% |
| Aduro Biotech, Inc. | Health Care | 0.6% |
| The Rubicon Project, Inc. | Consumer Discretionary | 0.6% |
| ESCO Technologies, Inc. | Industrials | 0.6% |
| Tactile Systems Technology, Inc. | Health Care | 0.6% |
| Black Diamond Therapeutics Inc | Health Care | 0.6% |
| uniQure NV | Health Care | 0.6% |
| Stoke Therapeutics Inc | Health Care | 0.6% |
| nLight Inc | Information Technology | 0.6% |
| Castle Biosciences Inc | Health Care | 0.6% |
| CryoPort Inc | Health Care | 0.5% |
| Natera, Inc. | Health Care | 0.5% |
| REVOLUTION Medicines Inc | Health Care | 0.5% |
| Impinj Inc | Information Technology | 0.5% |
| Everbridge, Inc. | Information Technology | 0.5% |
| Coherus Biosciences, Inc. | Health Care | 0.5% |
| 1-800-Flowers.com, Inc. | Consumer Discretionary | 0.5% |
| Inari Medical Inc | Health Care | 0.4% |
| Quanterix Corp | Health Care | 0.3% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 05/29/2020
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
1.1%
|
|
| Real Estate |
0.8%
|
|
| Utilities | 0.0% | |
| Consumer Discretionary |
3.1%
|
|
| Consumer Staples |
 0.7%
|
|
| Energy | 0.0% | |
| Financials |
2.5%
|
|
| Health Care |
0.3%
|
|
| Industrials |
1.0%
|
|
| Information Technology |
1.1%
|
|
| Materials | 0.0% |
Portfolio Details as of 05/29/2020
- Total Net Assets
- $135.90 M
- Number of Holdings
- 86
- Weighted Average Market Cap.
- 1.9 B
- P/B Ratio
- 5.5x
- P/E Ratio
- 21.8x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Contributors & Detractors as of 03/31/2020
Contributors
| Holding | Contribution |
|---|---|
| Forty Seven Inc | 1.0% |
| eHealth, Inc. | 0.6% |
| Twist Bioscience Corp | 0.5% |
| Limelight Networks, Inc. | 0.5% |
| Everbridge, Inc. | 0.2% |
Detractors
| Holding | Contribution |
|---|---|
| Comtech Telecommunications Corp. | -1.2% |
| AAR Corp. | -0.9% |
| Gogo, Inc. | -0.9% |
| Select Comfort Corp. | -0.9% |
| Myovant Sciences Ltd | -0.8% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Micro Cap Growth Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to the Fund's performance results for longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 07/08/2020
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2020 | 11/24/2020 | 11/24/2020 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/20/2019 | 11/21/2019 | $2.3699 | - | $2.3699 | $12.12 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/23/2020 | 11/24/2020 |
Fees & Expenses
Fees & Expenses
Expense Ratioas of 06/30/2020
| 1.31% |
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
| n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||